<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IFRX
InflaRx
$
()


  • InflaRx price target lowered by $1 at H.C. Wainwright, here's why

    1/25/2024 - 11:14am
  • InflaRx announces initiation of its commitment program for GOHIBIC

    1/25/2024 - 07:32am
  • InflaRx announces 'positive' topline results from MAD Phase I study of INF904

    1/4/2024 - 07:02am
  • Biotech Alert: Searches spiking for these stocks today

    11/6/2023 - 11:19am
  • InflaRx announces first patient dosed in Phase III trial

    11/6/2023 - 07:47am
  • InflaRx reports Q3 EPS (EUR 0.13) vs (EUR 0.18) last year

    11/1/2023 - 07:35am
  • InflaRx announces results from its SAD Phase I study with INF904

    9/11/2023 - 07:15am
  • InflaRx MAA for vilobelimab under review by EMA

    8/30/2023 - 07:34am
  • InflaRx expects cash to fund operations at least into 2026

    8/10/2023 - 07:35am
  • InflaRx reports Q2 EPS (14c), consensus (34c)

    8/10/2023 - 07:35am
  • InflaRx files $250M mixed securities shelf

    6/30/2023 - 16:08pm
  • InflaRx appoints Chong as Chief Medical Officer

    6/28/2023 - 07:31am
  • InflaRx announces commercial launch of Gohibic in the U.S.

    6/21/2023 - 07:11am
  • InflaRx reports Q1 EPS (25c), consensus (30c)

    5/11/2023 - 07:41am
  • Largest borrow rate increases among liquid names

    5/3/2023 - 08:45am
dynamic_feed Breaking News